GlassScriptPhysician profile
Bradley Edward Burget
NPI 1043531106
$4,125.33
in general payments reported to CMS, 2019-2025
32 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $364 · 2021: $543 · 2022: $423 · 2023: $1,588 · 2024: $320 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431 · Travel and Lodging: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.30 |
| Travel and Lodging | $817.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim International Gmbh | $1,307.34 | 2023 | |
| Pfizer INC. | $768.22 | 2019-2025 | |
| Lilly USA, LLC | $263.60 | 2019-2023 | Jardiance, Emgality |
| Novo Nordisk INC | $259.46 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $220.16 | 2022-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.43 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $188.28 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Amgen INC. | $127.78 | 2019-2023 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $93.05 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amarin Pharma, INC. | $57.25 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $50.34 | 2021-2024 | Airsupra |
| Eisai INC. | $45.55 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $45.16 | 2019-2023 | |
| Currax Pharmaceuticals LLC | $44.90 | 2022-2024 | Onzetra Xsail, Contrave |
| Abbott Laboratories | $40.78 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $40.43 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.15 | 2022-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $31.14 | 2024-2025 | |
| Astellas Pharma US INC | $31.08 | 2024 | Veozah |
| Kowa Pharmaceuticals America, INC. | $30.16 | 2019-2021 | |
| Celgene Corporation | $28.35 | 2019 | |
| Axsome Therapeutics, INC. | $27.84 | 2025 | Symbravo |
| Exact Sciences Corporation | $26.23 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $23.76 | 2024 | Thinprep 2000 Processor |
| Kaleo, INC. | $20.18 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.06 | 2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $17.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.30 | 2020 | |
| Horizon Therapeutics Plc | $16.23 | 2019 | |
| Lundbeck LLC | $14.11 | 2025 | Rexulti |
| Ibsa Pharma INC. | $13.90 | 2022 | |
| Dynavax Technologies Corporation | $6.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Burget listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.